English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12189/12972 (94%)
Visitors : 954316      Online Users : 697
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection Statistics

    近3年內發表的文件:10(55.56%)
    含全文筆數:18(100.00%)

    文件下載次數統計
    下載大於0次:18(100.00%)
    下載大於100次:17(94.44%)
    檔案下載總次數:3880(100.00%)

    最後更新時間: 2024-12-03 09:36


    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目1-10 / 18. (共2頁)
    1 2 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2024-06-24 Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease European Polymer Journal. 2024 Jun 24;214:Article number 113151.
    2024-05-09 Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function Journal of Biomedical Science. 2024 May 09;31:Article number 46.
    2023-11 Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death Pharmacological Research. 2023 Nov;197:Article number 106945.
    2023-03-28 Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
    2023-02-28 How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
    2023-02-03 MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
    2023-01-19 The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b [Erratum:Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.] Pharmaceutics. 2023 Jan 19;15(2):Article number 342.
    2022-07-21 The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.
    2022-03-16 Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.
    2022-03-02 Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782.

    顯示項目1-10 / 18. (共2頁)
    1 2 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋